GB9308654D0 - Therapeutic triazine compounds and use - Google Patents

Therapeutic triazine compounds and use

Info

Publication number
GB9308654D0
GB9308654D0 GB939308654A GB9308654A GB9308654D0 GB 9308654 D0 GB9308654 D0 GB 9308654D0 GB 939308654 A GB939308654 A GB 939308654A GB 9308654 A GB9308654 A GB 9308654A GB 9308654 D0 GB9308654 D0 GB 9308654D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic
triazine compounds
triazine
compounds
therapeutic triazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939308654A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB939308654A priority Critical patent/GB9308654D0/en
Publication of GB9308654D0 publication Critical patent/GB9308654D0/en
Priority to PCT/GB1993/001243 priority patent/WO1993025207A1/en
Priority to DE69307705T priority patent/DE69307705T2/en
Priority to YU41093A priority patent/YU48573B/en
Priority to ES93913346T priority patent/ES2097516T3/en
Priority to AT93913346T priority patent/ATE147980T1/en
Priority to HR930964A priority patent/HRP930964B1/en
Priority to NZ253260A priority patent/NZ253260A/en
Priority to CA002137782A priority patent/CA2137782A1/en
Priority to EP93913346A priority patent/EP0644763B1/en
Priority to AU43452/93A priority patent/AU688729B2/en
Priority to DK93913346.8T priority patent/DK0644763T3/en
Priority to KR1019940704501A priority patent/KR100268823B1/en
Priority to SI9300318A priority patent/SI9300318A/en
Priority to MYPI93001153A priority patent/MY109330A/en
Priority to IL10598693A priority patent/IL105986A/en
Priority to US08/347,480 priority patent/US5801171A/en
Priority to GB9423697A priority patent/GB2282326A/en
Priority to SK1534-94A priority patent/SK279730B6/en
Priority to JP50128194A priority patent/JP3439211B2/en
Priority to CZ943128A priority patent/CZ284061B6/en
Priority to TW082109982A priority patent/TW284689B/zh
Priority to NO944790A priority patent/NO306451B1/en
Priority to GR970400358T priority patent/GR3022671T3/en
Pending legal-status Critical Current

Links

GB939308654A 1992-06-12 1993-04-27 Therapeutic triazine compounds and use Pending GB9308654D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use
CZ943128A CZ284061B6 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine or a pharmaceutically or veterinary acceptable salt thereof for preparing a medicament
AU43452/93A AU688729B2 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
KR1019940704501A KR100268823B1 (en) 1992-06-12 1993-06-11 Pharmaceutical compositon containing 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs
YU41093A YU48573B (en) 1992-06-12 1993-06-11 Application of 3,5-diamyno-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for treatment and prevention of dependence, tolerance and sensitization of drugs
ES93913346T ES2097516T3 (en) 1992-06-12 1993-06-11 USE OF 3,5-DIAMINO-6- (2,3-DICHLOROPHENYL) -1,2,4-TRIAZINE ISETIONATE FOR THE TREATMENT AND PREVENTION OF DEPENDENCY, TOLERANCE AND SENSITIVITY TO DRUGS AND DRUGS.
AT93913346T ATE147980T1 (en) 1992-06-12 1993-06-11 USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4,-TRIAZ NISETHIONATE FOR THE TREATMENT AND PREVENTION OF DRUG DEPENDENCE, TOLERANCE AND SENSITIZATION
HR930964A HRP930964B1 (en) 1992-06-12 1993-06-11 Therapeutic triazine compounds and the use thereof
NZ253260A NZ253260A (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine (lamotrigine) for preparing medicaments for preventing or reducing dependence on (or tolerance to or reverse tolerance to) a dependence-inducing agent
CA002137782A CA2137782A1 (en) 1992-06-12 1993-06-11 Therapeutic triazine compounds and use
EP93913346A EP0644763B1 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
PCT/GB1993/001243 WO1993025207A1 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
DK93913346.8T DK0644763T3 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triacin isethionate for the treatment and prevention of drug dependence, tolerance and sensitization
DE69307705T DE69307705T2 (en) 1992-06-12 1993-06-11 USE OF 3,5-DIAMINO-6- (2,3-DICHLOROPHENYL) -1,2,4, -TRIAZINISETHIONATE FOR THE TREATMENT AND PREVENTION OF DRUG ADDICTION, TOLERANCE AND SENSITIZATION
SI9300318A SI9300318A (en) 1992-06-12 1993-06-11 Therapeutic triazine compounds and use thereof
MYPI93001153A MY109330A (en) 1992-06-12 1993-06-11 Therapeutic triazine compounds and use.
IL10598693A IL105986A (en) 1992-06-12 1993-06-11 Pharmaceutical compositions containing triazine compounds for preventing or reducing dependence tolerance or reverse tolerance to a dependence-inducing agent
US08/347,480 US5801171A (en) 1992-06-12 1993-06-11 Use of 3, 5-diamino-6-(2,3-dichlorophenyl)-1, 2, 4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs
GB9423697A GB2282326A (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3 dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence,tolerance and sensitization of drugs
SK1534-94A SK279730B6 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable salts
JP50128194A JP3439211B2 (en) 1992-06-12 1993-06-11 Use of 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine isethionate in the treatment and prevention of dependence, tolerance and sensitization to drugs
TW082109982A TW284689B (en) 1992-06-12 1993-11-26
NO944790A NO306451B1 (en) 1992-06-12 1994-12-09 Use of 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine isionate for the treatment and prevention of dependence, tolerance and sensitization of drugs, the mixture of the triazine isionate with an addiction inducing agent, a preparation and a prodrug.
GR970400358T GR3022671T3 (en) 1992-06-12 1997-02-26 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use

Publications (1)

Publication Number Publication Date
GB9308654D0 true GB9308654D0 (en) 1993-06-09

Family

ID=10734527

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939308654A Pending GB9308654D0 (en) 1992-06-12 1993-04-27 Therapeutic triazine compounds and use

Country Status (1)

Country Link
GB (1) GB9308654D0 (en)

Similar Documents

Publication Publication Date Title
GB9422158D0 (en) N-acylindoles and related compounds
GB9300051D0 (en) Therapeutic agents
ZA947833B (en) 4-Arylamino-benzopyran and related compounds
ZA941926B (en) Heterocyclic compounds their preparation and use
GB9305644D0 (en) Therapeutic agents
GB9305692D0 (en) Therapeutic triazine compounds and use
ZA946217B (en) Therapeutic combination
GB9319772D0 (en) Therapeutic agent
ZA941938B (en) Therapeutic triazine compounds and use
GB9308654D0 (en) Therapeutic triazine compounds and use
GB9311223D0 (en) Compounds and use
GB9308091D0 (en) Compounds and use
GB9302314D0 (en) Novel compounds and treatment
GB9321592D0 (en) Novel compounds and treatment
GB9321591D0 (en) Novel compounds and treatment
GB9302289D0 (en) Novel compounds and treatment
GB9226056D0 (en) Therapeutic use
GB9226047D0 (en) Therapeutic use
GB9220714D0 (en) Therapeutic use
GB9308962D0 (en) Therapeutic agetns
GB9306646D0 (en) Therapeutic agetns
GB9226728D0 (en) Therapeutic combination
GB9323437D0 (en) Therapy
GB9303913D0 (en) Compound and use
GB9303843D0 (en) Therapeutic agents